Site specific binding system, nuclear imaging compositions and methods
AssigneeBarnes-Jewish Hospital
InventorsGregory M. Lanza, Samuel A. Wickline
Life of this patent
Estimating the term…
Loading patent…
AssigneeBarnes-Jewish Hospital
InventorsGregory M. Lanza, Samuel A. Wickline
Estimating the term…
A method for ligand-based binding of lipid encapsulated particles to molecular epitopes on a surface in vivo or in vitro comprises sequentially administering (a) a site-specific ligand activated with a biotin activating agent; (b) an avidin activating agent; and (c) lipid encapsulated particles activated with a biotin activating agent, whereby the ligand is conjugated to the particles through an avidin-biotin interaction and the resulting conjugate is bound to the molecular epitopes on such surface. The conjugate is effective for imaging by x-ray, ultrasound, magnetic resonance, positron emission tomography or nuclear imaging. Compositions for use in ultrasonic imaging of natural or synthetic surfaces and for enhancing the acoustic reflectivity thereof are also disclosed.
A method for nuclear imaging in vivo through ligand-based binding of an emulsion to a surface to be imaged comprising administering to said surface:
A composition for use in nuclear imaging of a biological surface comprising a biotinylated lipid coated emulsion containing a radionuclide and a fluorochemical.
A composition formed in vivo and permitting nuclear imaging of a biological surface to which it is bound, said composition comprising:
Dependencies are inferred from the claim text.